BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31330377)

  • 1. Transmitted drug resistance in newly diagnosed and treatment-naïve HIV type 1-infected patients in Hungary.
    Áy É; Müller V; Mezei M; Pocskay Á; Koroknai A; Müller D; Győri Z; Marschalkó M; Tóth B; Kárpáti S; Lakatos B; Szlávik J; Takács M; Minárovits J
    J Glob Antimicrob Resist; 2020 Mar; 20():124-130. PubMed ID: 31330377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
    Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.
    Grgic I; Lepej SZ; Lunar MM; Poljak M; Vince A; Vrakela IB; Planinic A; Seme K; Begovac J
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):329-36. PubMed ID: 22906365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
    Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
    PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
    Alexiev I; Shankar A; Wensing AM; Beshkov D; Elenkov I; Stoycheva M; Nikolova D; Nikolova M; Switzer WM
    J Antimicrob Chemother; 2015; 70(6):1874-80. PubMed ID: 25652746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience.
    Mazzuti L; Melengu T; Falasca F; Calabretto M; Cella E; Ciccozzi M; Mezzaroma I; Iaiani G; Spaziante M; d'Ettorre G; Fimiani C; Vullo V; Antonelli G; Turriziani O
    J Glob Antimicrob Resist; 2020 Mar; 20():298-303. PubMed ID: 31518723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
    Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
    Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitted drug resistance and transmission clusters among ART-naïve HIV-1-infected individuals from 2019 to 2021 in Nanjing, China.
    Xu Y; Shi H; Dong X; Ding C; Wu S; Li X; Zhang H; Qiao M; Li X; Zhu Z
    Front Public Health; 2023; 11():1179568. PubMed ID: 37674678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitted HIV drug resistance in treatment-naive Romanian patients.
    Temereanca A; Ene L; Mehta S; Manolescu L; Duiculescu D; Ruta S
    J Med Virol; 2013 Jul; 85(7):1139-47. PubMed ID: 23592112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.
    Zhou C; Liang S; Li Y; Zhang Y; Li L; Ye L; Yuan D; Su L
    BMC Infect Dis; 2022 Jul; 22(1):602. PubMed ID: 35799101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria.
    Nazziwa J; Njai HF; Ndembi N; Birungi J; Lyagoba F; Gershim A; Nakiyingi-Miiro J; Nielsen L; Mpendo J; Nanvubya A; Debont J; Grosskurth H; Kamali A; Seeley J; Kaleebu P;
    AIDS Res Hum Retroviruses; 2013 May; 29(5):788-95. PubMed ID: 23173702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
    Vergne L; Peeters M; Mpoudi-Ngole E; Bourgeois A; Liegeois F; Toure-Kane C; Mboup S; Mulanga-Kabeya C; Saman E; Jourdan J; Reynes J; Delaporte E
    J Clin Microbiol; 2000 Nov; 38(11):3919-25. PubMed ID: 11060045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
    Bokharaei-Salim F; Esghaei M; Khanaliha K; Kalantari S; Marjani A; Fakhim A; Keyvani H
    PLoS One; 2020; 15(3):e0229275. PubMed ID: 32119691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China.
    Zhao S; Feng Y; Hu J; Li Y; Zuo Z; Yan J; Zhang J; Cao P; Xu W; Li F; Li Y; Liao L; Ruan Y; Shao Y; Xing H
    Sci Rep; 2018 Aug; 8(1):12273. PubMed ID: 30115986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.